Discussion on unusual blood clots observed by embalmers, highlighting the importance of scientific inquiry and clinical recognition.
-
Emphasizing the need for scientific understanding and careful observation in analyzing unusual blood clot patterns. • 0:14
-
Acknowledging the efforts of Tom Havland in investigating abnormal clotting patterns and seeking input from experts worldwide. • 1:00
-
Describing the scientific observation of stringy fibrous elastic clots during embalming procedures, prompting questions about mechanisms and significance. • 1:25
-
Discussing the potential role of amyloid fibrin clots and the need for clinical evaluation of clotting criteria and response to anti-coagulation. • 1:57
-
Urging viewers, especially clinicians, to watch an important interview with a whistleblower providing visual evidence of the observed blood clots. • 2:58
-
Previewing upcoming content featuring an interview with Grant Stenfield and promising further scientific analysis on the topic. • 3:36
-
Offering insights into the mechanism behind the unusual blood clotting phenomenon and expressing the need for continued investigation. • 4:23
Discovery of white fibrous clots in living individuals raises concerns about potential health risks.
-
White fibrous clots observed in living individuals, not just in deceased cases. • 4:54
-
Cath lab workers also reporting finding these clots in living patients. • 5:24
-
Data analyst and former Air Force Major discusses ongoing research on these clots. • 5:35
-
Survey results show a high percentage of embalmers still encountering these clots. • 6:03
-
Whistleblowers confirm existence of white fibrous clots in living individuals for the past three years. • 6:39
-
Discussion on the potential mechanisms behind the formation of these clots in the vascular system. • 7:01
-
Explanation of the circulatory system highlighting the path of arteries and veins in the body. • 8:03
Discussion on abnormal protein deposition in blood vessels leading to clot formation.
-
Abnormal protein deposition in inferior vena cava and arteries. • 8:50
-
Inflammation in blood vessels triggering clot formation. • 9:15
-
Importance of smooth blood vessel lining in preventing clots. • 10:00
-
Presence of vasorum supplying nutrition to blood vessel walls. • 10:19
-
Evidence of clots in big veins due to inflammation. • 10:51
-
Concerns about whistleblowers’ fear hindering information disclosure. • 13:10
-
Urgency in addressing serious clinical implications of abnormal protein deposition. • 13:19
Whistleblower reveals high percentage of vaccinated patients with white fibrous clots, sparking fear among medical professionals.
-
Whistleblower reports 99% of patients with clots were vaccinated. • 13:52
-
White fibrous clots predominantly seen in vaccinated individuals. • 15:31
-
High number of clots being treated weekly in vaccinated patients. • 16:09
-
Concerns raised about the safety and efficacy of vaccines. • 16:33
-
Multiple whistleblowers from different regions corroborate findings. • 16:57
-
Medical professionals hesitant to speak out due to fear of repercussions. • 17:26
-
FDA and CDC reluctance to investigate the issue. • 17:37
Serious concerns raised about potential clotting issues in patients post-vaccination.
-
Concerns about clotting issues post-vaccination impacting patients globally. • 17:43
-
Highlighted seriousness of potential clot removal frequency in patients. • 17:49
-
Fear among people discussing potential vaccine-related issues. • 18:13
-
Urgent need to address clinical questions on clotting mechanisms and treatments. • 19:29
-
Call for researchers to investigate and find solutions to protect patients. • 20:23
-
Encouragement for medical professionals to engage in critical discussions and research. • 20:46
-
Importance of ensuring patient safety and advocating for thorough investigations. • 21:06